The globalisation of clinical research is accelerating, with a growing share of trials now conducted in emerging markets across Asia, Latin America and Africa. Venturing into new regions offers clear advantages, including opportunity to reach diverse patient populations, speed recruitment and address areas of high unmet medical need. And while opportunities are plentiful, so too are the challenges of assuring safe, compliant and timely supply to patients.